Pharmaceutical Research: Multi-Compartmental Vaccine Delivery System for Enhanced Immune Response to gp100 Peptide Antigen in Melanoma Immunotherapy
20:00 EDT 17 Jul 2012 | PharmaGateway
Type: Original PaperPurposeTo develop a multi-compartmental vaccine delivery system for safe and efficient delivery of the gp100 peptide antigen in melanoma immunotherapy.MethodsWater-in-oil-in-water (W/O/W) multiple emulsion-based multi-compartmenta..
Original Article: Pharmaceutical Research: Multi-Compartmental Vaccine Delivery System for Enhanced Immune Response to gp100 Peptide Antigen in Melanoma Immunotherapy
More From BioPortfolio on "Pharmaceutical Research: Multi-Compartmental Vaccine Delivery System for Enhanced Immune Response to gp100 Peptide Antigen in Melanoma Immunotherapy"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
